このページの翻訳は実験的なもので、現在開発中です。お待ちしております
ORIC Pharmaceuticals 将来の成長
Future 基準チェック /06
ORIC Pharmaceuticalsの収益は年間1.5%で減少すると予測されていますが、年間収益は年間40.1%で増加すると予測されています。EPS は年間 増加すると予測されています。自己資本利益率は 3 年後に-47.9% 2.3%なると予測されています。
主要情報
-5.9%
収益成長率
2.2%
EPS成長率
| Biotechs 収益成長 | 28.4% |
| 収益成長率 | 54.4% |
| 将来の株主資本利益率 | -47.9% |
| アナリストカバレッジ | Good |
| 最終更新日 | 23 Sep 2024 |
今後の成長に関する最新情報
Recent updates
Here's Why We're Not Too Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn Situation
Aug 21
ORIC Pharmaceuticals Stock: Too Early To Justify This Valuation
Jul 29ORIC Pharma: ORIC-114 Advancement To Phase 1b Expansion Study Could Yield Value
Jul 17We're Hopeful That ORIC Pharmaceuticals (NASDAQ:ORIC) Will Use Its Cash Wisely
May 08ORIC Pharmaceuticals: Mid-2024 Prostate Cancer Program Update Could Lead To Gains
Mar 13We're Not Very Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn Rate
Jan 18We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
Sep 27ORIC Pharmaceuticals (NASDAQ:ORIC) Is In A Good Position To Deliver On Growth Plans
Jun 14Companies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In Growth
Jan 24ORIC Pharmaceuticals: Poster Child For The Current Downturn In Biotech
Oct 14Is ORIC Pharmaceuticals (NASDAQ:ORIC) In A Good Position To Deliver On Growth Plans?
Oct 08ORIC Pharmaceuticals GAAP EPS of -$0.51 beats by $0.09
Aug 11ORIC Pharmaceuticals (NASDAQ:ORIC) Is In A Good Position To Deliver On Growth Plans
Jun 24We're Hopeful That ORIC Pharmaceuticals (NASDAQ:ORIC) Will Use Its Cash Wisely
Mar 08We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
Nov 23We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
Aug 05ORIC Pharmaceuticals EPS beats by $0.04
May 06Here's Why We're Not Too Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn Situation
Apr 16We're Hopeful That ORIC Pharmaceuticals (NASDAQ:ORIC) Will Use Its Cash Wisely
Jan 01
Oric Pharma starts expansion phase of mid-stage solid tumor study with ORIC-101
Dec 21Oric Pharma prices stock offering at $23
Nov 13業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 14 | -177 | -181 | -148 | 7 |
| 12/31/2025 | N/A | -156 | -128 | -113 | 10 |
| 12/31/2024 | N/A | -126 | -92 | -75 | 10 |
| 6/30/2024 | N/A | -111 | -100 | -100 | N/A |
| 3/31/2024 | N/A | -102 | -96 | -95 | N/A |
| 12/31/2023 | N/A | -101 | -87 | -86 | N/A |
| 9/30/2023 | N/A | -93 | -78 | -77 | N/A |
| 6/30/2023 | N/A | -93 | -78 | -76 | N/A |
| 3/31/2023 | N/A | -90 | -75 | -73 | N/A |
| 12/31/2022 | N/A | -89 | -77 | -75 | N/A |
| 9/30/2022 | N/A | -91 | -78 | -76 | N/A |
| 6/30/2022 | N/A | -85 | -71 | -69 | N/A |
| 3/31/2022 | N/A | -85 | -69 | -67 | N/A |
| 12/31/2021 | N/A | -79 | -60 | -60 | N/A |
| 9/30/2021 | N/A | -84 | -62 | -61 | N/A |
| 6/30/2021 | N/A | -91 | -59 | -59 | N/A |
| 3/31/2021 | N/A | -81 | -53 | -52 | N/A |
| 12/31/2020 | N/A | -74 | -46 | -45 | N/A |
| 9/30/2020 | N/A | -54 | -35 | -35 | N/A |
| 6/30/2020 | N/A | -35 | -31 | -30 | N/A |
| 3/31/2020 | N/A | -30 | -27 | -26 | N/A |
| 12/31/2019 | N/A | -27 | -24 | -24 | N/A |
| 12/31/2018 | N/A | -21 | -21 | -21 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: ORIC今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: ORIC今後 3 年間、利益が出ない状態が続くと予測されています。
高成長収益: ORIC今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: ORIC来年は収益がないと予測されています。
高い収益成長: ORIC来年は収益がないと予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: ORIC 3 年以内に赤字になると予測されています。